| 000 | 01636 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514235012.0 | ||
| 264 | 0 | _c20050908 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Zhuo | |
| 245 | 0 | 0 |
_aDifferential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a2367-79 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntimycin A _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCASP8 and FADD-Like Apoptosis Regulating Protein |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aG2 Phase _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xgenetics |
| 650 | 0 | 4 |
_aPaclitaxel _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTaxoids _xpharmacology |
| 650 | 0 | 4 | _abcl-X Protein |
| 700 | 1 | _aGoulet, Robert | |
| 700 | 1 | _aStanton, Katie J | |
| 700 | 1 | _aSadaria, Miral | |
| 700 | 1 | _aNakshatri, Harikrishna | |
| 773 | 0 |
_tAnticancer research _gvol. 25 _gno. 3c _gp. 2367-79 |
|
| 999 |
_c15719166 _d15719166 |
||